The new era of wearable devices has brought us the potential, though limited, to
monitor our health. The main purpose of cardiovascular monitoring is the detection
of AF (atrial fibrillation). Modern wearables can not only detect but also send realtime
alerts to users, often before they can feel the arrhythmia. The quick adoption of
these tools into daily life, though, has also opened up many discussions—technical,
medical, and ethical (sometimes all tangled together). Many wearables remain
outside the official validation of regulatory bodies, and their accuracy shifts
depending on the group being tested (older patients or those with multiple
conditions tend to experience more variability). Collecting highly sensitive cardiac
data also introduces another layer of concern, especially when companies control
the information (users often accept lengthy agreements without reading them at
all). Smartwatch notifications regularly push people to book a consultation, even if
the trigger was something minor or harmless. Healthcare providers may find
opportunities in this trend—for example, by spotting disease earlier—but at the
same time the system risks becoming overloaded by the extra number of visits.
These devices are not yet capable of replacing traditional diagnostics, such as the
12-lead ECG, but they are reshaping the way patients engage with their health.
Wearables merge consumer gadgets with clinical tools, making careful evaluation,
regulation, and evidence-based integration essential to help patients benefit safely
(minimizing potential harm).
Keywords: Monitoring heart health with wearables, Early detection of atrial
fibrillation (AF), Safeguarding data privacy and ethics, Incorporating digital health
into clinical practice